TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 34340242

Group type: EXPERIMENTAL
Intervention: Text-based reminders delivered one day after notification of vaccine eligibility
Number of subjects: 160446

Group type: EXPERIMENTAL
Intervention: Text-based reminders delivered eight days after notification of vaccine eligibility
Number of subjects: 160446

Group type: EXPERIMENTAL
Intervention: First reminder designed to induce feelings of ownership over the vaccine dose
Number of subjects: 160446

Group type: COMPARATOR
Intervention: Combination of first reminder with a video-based information intervention
Number of subjects: 160446
Study: 32660848

Group type: EXPERIMENTAL
Intervention: Self-reported voice problems
Number of subjects: 426

Group type: EXPERIMENTAL
Intervention: Voice problems
Number of subjects: 426
Study: 33894465

Group type: EXPERIMENTAL
Intervention: Orthopedic insoles (OIs)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Sham insole (SI)
Number of subjects: 32
Study: 35757330

Group type: EXPERIMENTAL
Intervention: Shenqisuxin granule (SQSX) plus conventional treatment
Number of subjects: 66

Group type: COMPARATOR
Intervention: Placebo plus conventional treatment
Number of subjects: 66
Study: 33257037

Group type: EXPERIMENTAL
Intervention: Negative pressure wound therapy
Number of subjects: 100

Group type: COMPARATOR
Intervention: Standard sterile dressing
Number of subjects: 100
Study: 33864390

Group type: EXPERIMENTAL
Intervention: Marital First Responders‐AA, a culturally adapted version of the Marital First Responders program
Number of subjects: 0
Study: 33188136

Group type: EXPERIMENTAL
Intervention: Tofacitinib (TOFA)
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: Baricitinib (BARI)
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: Upadacitinib (UPA)
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: Filgotinib (FILGO)
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: Decernotinib (DEC)
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: Peficitinib (PEF)
Number of subjects: 85

Group type: COMPARATOR
Intervention: JAK inhibitors (JAKi)
Number of subjects: 85

Group type: COMPARATOR
Intervention: Control (TNFi)
Number of subjects: 85
Study: 34429511

Group type: EXPERIMENTAL
Intervention: LION procedure
Number of subjects: 17

Group type: COMPARATOR
Intervention: NMES
Number of subjects: 17
Study: 34269398

Group type: EXPERIMENTAL
Intervention: Specific vasoactive therapy
Number of subjects: 1

Group type: COMPARATOR
Intervention: Underlying heart and lung disease treatment
Number of subjects: 1
Study: 32666060

Group type: EXPERIMENTAL
Intervention: Regular mode polymerization (600‐650 mW/cm2 for 20 s)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: High-power mode polymerization (1200‐1300 mW/cm2 for 10 s)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Both polymerization modes (Regular and High-power)
Number of subjects: 50
Study: 35344441

Group type: EXPERIMENTAL
Intervention: Procedural Justice (PJ) training
Number of subjects: 0
Study: 33373541

Group type: EXPERIMENTAL
Intervention: Silver Diamine Fluoride (SDF)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: CO2 Laser
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: CO2 Laser followed by SDF
Number of subjects: 40

Group type: COMPARATOR
Intervention: No treatment (Control)
Number of subjects: 40
Study: 32709516

Group type: EXPERIMENTAL
Intervention: Kinesio Taping (KT) and Postural Correction Exercises (PCE)
Number of subjects: 91

Group type: COMPARATOR
Intervention: Postural Correction Exercises (PCE)
Number of subjects: 91

Group type: COMPARATOR
Intervention: Kinesio Taping (KT)
Number of subjects: 91
Study: 35719836

Group type: EXPERIMENTAL
Intervention: Lycii Fructus extract (LFE) 900 mg/day
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 32899031

Group type: EXPERIMENTAL
Intervention: Recombinant tissue plasminogen activator thrombolytic therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 33996266

Group type: EXPERIMENTAL
Intervention: High intratumoral CXCL13+CD8+ T cells infiltration
Number of subjects: 440

Group type: EXPERIMENTAL
Intervention: CXCL13+CD8+ T cells
Number of subjects: 440

Group type: EXPERIMENTAL
Intervention: Combinational analysis of CXCL13+CD8+ T cells and CD8+ T cells infiltration
Number of subjects: 440

Group type: EXPERIMENTAL
Intervention: Intratumoral CXCL13+CD8+ T cells infiltration
Number of subjects: 440
Study: 34677668

Group type: EXPERIMENTAL
Intervention: Radiomics nomogram
Number of subjects: 205

Group type: EXPERIMENTAL
Intervention: Radiomics signature
Number of subjects: 205
Study: 33354769

Group type: EXPERIMENTAL
Intervention: Daily smartphone-based monitoring including a feedback loop
Number of subjects: 98

Group type: COMPARATOR
Intervention: Standard treatment
Number of subjects: 98
Study: 32928255

Group type: EXPERIMENTAL
Intervention: Early parenteral nutrition (PN)
Number of subjects: 1128

Group type: COMPARATOR
Intervention: Late parenteral nutrition (PN)
Number of subjects: 1128

Group type: EXPERIMENTAL
Intervention: Upon-admission GDF15
Number of subjects: 1128

Group type: EXPERIMENTAL
Intervention: Lower GDF15
Number of subjects: 1128
Study: 35332521

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided proximal suprascapular nerve block with 5 ml ropivacaine 7.5 mg/ml
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo (5 ml isotonic NaCl)
Number of subjects: 0
Study: 33106167

Group type: EXPERIMENTAL
Intervention: Standard care and 200 ml convalescent plasma (CP)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Standard care and 400 ml convalescent plasma (CP)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Standard care and 200 ml CP
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Standard care and 400 ml CP
Number of subjects: 60
Study: 36173384

Group type: EXPERIMENTAL
Intervention: Milk powder
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: Whole egg powder
Number of subjects: 122

Group type: COMPARATOR
Intervention: Gelatin (placebo)
Number of subjects: 122
Study: 34236768

Group type: EXPERIMENTAL
Intervention: Intermediate dose enoxaparin
Number of subjects: 176

Group type: COMPARATOR
Intervention: Standard prophylactic dose enoxaparin
Number of subjects: 176
Study: 32369460

Group type: EXPERIMENTAL
Intervention: Mannitol solution
Number of subjects: 140

Group type: COMPARATOR
Intervention: Polyethylene glycol (PEG)
Number of subjects: 140
Study: 35669372

Group type: EXPERIMENTAL
Intervention: Observation group (image recognition algorithm for feature extraction, segmentation, and classification)
Number of subjects: 268

Group type: COMPARATOR
Intervention: Control group (standard classification method)
Number of subjects: 268
Study: 34023746

Group type: EXPERIMENTAL
Intervention: Antidepressant medication (specific type not mentioned)
Number of subjects: 665

Group type: COMPARATOR
Intervention: Control group (placebo)
Number of subjects: 665
Study: 35483181

Group type: EXPERIMENTAL
Intervention: Interpersonal consequences
Number of subjects: 349

Group type: EXPERIMENTAL
Intervention: Intrapersonal consequences (e.g., sad mood)
Number of subjects: 349

Group type: EXPERIMENTAL
Intervention: Social responsibility consequences (particularly financial)
Number of subjects: 349

Group type: EXPERIMENTAL
Intervention: Alcohol consumption measures
Number of subjects: 349
Study: 33368991

Group type: EXPERIMENTAL
Intervention: Ultrasonography guided penile nerve block (PNB)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control (no PNB)
Number of subjects: 80
Study: 33516790

Group type: EXPERIMENTAL
Intervention: Grade 3 rENE
Number of subjects: 1887

Group type: COMPARATOR
Intervention: Proposed N category system
Number of subjects: 1887
Study: 34126426

Group type: EXPERIMENTAL
Intervention: Predisposition condition (indicating heightened schizophrenia risk)
Number of subjects: 1601

Group type: EXPERIMENTAL
Intervention: No-predisposition condition (indicating no heightened schizophrenia risk)
Number of subjects: 1601

Group type: COMPARATOR
Intervention: Control condition (no mention of genetic testing)
Number of subjects: 1601

Group type: EXPERIMENTAL
Intervention: Predisposition condition (in Experiment 2)
Number of subjects: 1601

Group type: EXPERIMENTAL
Intervention: No-predisposition condition (in Experiment 2)
Number of subjects: 1601
Study: 36137627

Group type: EXPERIMENTAL
Intervention: Clonidine during ROP eye examinations
Number of subjects: 0
Study: 33978132

Group type: EXPERIMENTAL
Intervention: Home-based (HB) aerobic training combined with food orientation
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Supervised (face‐to‐face, FF) aerobic training combined with food orientation
Number of subjects: 23

Group type: COMPARATOR
Intervention: Both HB and FF groups
Number of subjects: 23
Study: 32169523

Group type: EXPERIMENTAL
Intervention: Motivational interviewing
Number of subjects: 262

Group type: EXPERIMENTAL
Intervention: Behavioral skills training
Number of subjects: 262

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 262
Study: 34302120

Group type: EXPERIMENTAL
Intervention: Total Diet Replacement (TDR) for 8 weeks, followed by food-reintroduction over 4 weeks, with weekly behavioral support for 8 weeks, bi-weekly for 4 weeks, then monthly for 3 months
Number of subjects: 179

Group type: EXPERIMENTAL
Intervention: Total Diet Replacement (TDR)
Number of subjects: 179

Group type: COMPARATOR
Intervention: Usual Care (UC)
Number of subjects: 179
Study: 32784257

Group type: EXPERIMENTAL
Intervention: RED PBM
Number of subjects: 174

Group type: EXPERIMENTAL
Intervention: INFRARED PBM
Number of subjects: 174

Group type: COMPARATOR
Intervention: PLACEBO (Sham) treatment
Number of subjects: 174
Study: 34475171

Group type: EXPERIMENTAL
Intervention: Vaxcards incentive
Number of subjects: 3087

Group type: COMPARATOR
Intervention: Control group (no Vaxcards)
Number of subjects: 3087

Group type: EXPERIMENTAL
Intervention: Historical return rates
Number of subjects: 3087
Study: 32357314

Group type: EXPERIMENTAL
Intervention: FAAM‐D (digital version)
Number of subjects: 90

Group type: COMPARATOR
Intervention: FAAM‐P (paper version)
Number of subjects: 90
Study: 36279266

Group type: EXPERIMENTAL
Intervention: Low Level Laser Therapy (LLLT), administered three times a week for 3 weeks
Number of subjects: 47

Group type: COMPARATOR
Intervention: Extracorporeal Shock Wave Therapy (ESWT), administered once a week for 3 weeks
Number of subjects: 47
Study: 32698618

Group type: EXPERIMENTAL
Intervention: LASIK
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: F-SMILE
Number of subjects: 60

Group type: COMPARATOR
Intervention: Comparison between LASIK and F-SMILE
Number of subjects: 60
Study: 35966074

Group type: EXPERIMENTAL
Intervention: CHOICE diet (60% complex carbohydrate/25% fat/15% protein)
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: CHOICE diet
Number of subjects: 34

Group type: COMPARATOR
Intervention: CONV diet (40% complex carbohydrate/45% fat/15% protein)
Number of subjects: 34
Study: 32016653

Group type: EXPERIMENTAL
Intervention: Multivitamin supplementation (MV)
Number of subjects: 147

Group type: COMPARATOR
Intervention: No multivitamin supplementation (MV)
Number of subjects: 147

Group type: EXPERIMENTAL
Intervention: Both groups (with and without MV)
Number of subjects: 147
Study: 36177637

Group type: EXPERIMENTAL
Intervention: ReMotion TWA
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Motec TWA
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 40
Study: 34332453

Group type: EXPERIMENTAL
Intervention: Deliberate practice using a feedback device (FD) during CPR training
Number of subjects: 60
Study: 32078161

Group type: EXPERIMENTAL
Intervention: Direct visual targeting of the anterior thalamic nucleus (ANT)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Preset coordinates for ANT electrode implantation
Number of subjects: 12
Study: 616731945

Group type: EXPERIMENTAL
Intervention: Motorized vehicle-mounted sprayer (VMS)
Number of subjects: 76

Group type: COMPARATOR
Intervention: Manual compression sprayers (MCS)
Number of subjects: 76
Study: 35708481

Group type: EXPERIMENTAL
Intervention: Mézières Method (MM)
Number of subjects: 139

Group type: COMPARATOR
Intervention: Standard rehabilitation protocol
Number of subjects: 139
Study: 34789188

Group type: EXPERIMENTAL
Intervention: Training at a fitness center
Number of subjects: 3764

Group type: COMPARATOR
Intervention: No access to training (no-training arm)
Number of subjects: 3764
Study: 33249985

Group type: EXPERIMENTAL
Intervention: Cream with lipid nanoparticles and vitamin E (Group A)
Number of subjects: 108

Group type: COMPARATOR
Intervention: Cream without nanoparticles nor vitamin E (Group B)
Number of subjects: 108

Group type: COMPARATOR
Intervention: Cream with nanoparticles without vitamin E (Group C)
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: All groups (A, B, C)
Number of subjects: 108
Study: 35688438

Group type: EXPERIMENTAL
Intervention: Weight gain of 0 to 4.9 kg
Number of subjects: 16808

Group type: EXPERIMENTAL
Intervention: Weight loss during pregnancy
Number of subjects: 16808

Group type: EXPERIMENTAL
Intervention: Weight gain above recommendations (≥ 9.1 kg)
Number of subjects: 16808

Group type: COMPARATOR
Intervention: Weight gain within recommendations (5-9.09 kg)
Number of subjects: 16808
Study: 35904836

Group type: EXPERIMENTAL
Intervention: Platelet-rich fibrin (PRF)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Concentrated growth factors (CGF)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 36
Study: 33069668

Group type: EXPERIMENTAL
Intervention: Ibuprofen
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 99050181

Group type: EXPERIMENTAL
Intervention: Monetary alternative ($5.00 voucher)
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Active marijuana (1.8% or 3.9% THC)
Number of subjects: 7

Group type: COMPARATOR
Intervention: Placebo marijuana (0.0% THC)
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Task performance criteria (80, 100, or 120% of baseline)
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: THC concentration
Number of subjects: 7
Study: 32993355

Group type: EXPERIMENTAL
Intervention: Diet 2 (SFSe) with 12.605 mg/kg Se additive
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Diet 4 (USFSe) with 12.605 mg/kg Se additive
Number of subjects: 240

Group type: COMPARATOR
Intervention: Control diet 1 (SFC) with no added Se
Number of subjects: 240

Group type: COMPARATOR
Intervention: Control diet 3 (USFC) with no added Se
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Standard temperature (20°C)
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: High temperature (35°C)
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Selenium addition in both diets
Number of subjects: 240
Study: 32026826

Group type: EXPERIMENTAL
Intervention: Combined therapy (HA+HS with oscillatory‐PEP)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Usual care (HA+HS followed by autogenic drainage)
Number of subjects: 22
Study: 34543687

Group type: EXPERIMENTAL
Intervention: Intensive BP treatment (systolic BP <120 mm Hg)
Number of subjects: 716

Group type: COMPARATOR
Intervention: Standard BP treatment (systolic BP <140 mm Hg)
Number of subjects: 716
Study: 32658621

Group type: EXPERIMENTAL
Intervention: NCWS patients
Number of subjects: 12

Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 12
Study: 32318704

Group type: EXPERIMENTAL
Intervention: HBeAg-positive patients with lower HBsAg levels
Number of subjects: 2779

Group type: EXPERIMENTAL
Intervention: Genotype-specific HBsAg cutoffs
Number of subjects: 2779

Group type: EXPERIMENTAL
Intervention: Diagnostic performance of HBsAg cutoffs
Number of subjects: 2779
Study: 35363844

Group type: EXPERIMENTAL
Intervention: Silver closed vitrification system (CVS)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Slow freezing (SF)
Number of subjects: 9
Study: 35858179

Group type: EXPERIMENTAL
Intervention: Anterior glenoid angle measurement via MRI
Number of subjects: 90
Study: 34696811

Group type: EXPERIMENTAL
Intervention: Intervention group (brief counseling sessions and low-dose physical activity recommendations)
Number of subjects: 583

Group type: EXPERIMENTAL
Intervention: Intervention group
Number of subjects: 583
Study: 33025448

Group type: EXPERIMENTAL
Intervention: Community pharmacists' knowledge regarding malaria and its treatment
Number of subjects: 293

Group type: EXPERIMENTAL
Intervention: Community pharmacists' practices regarding antimalarials dispensing
Number of subjects: 293

Group type: EXPERIMENTAL
Intervention: Barriers to effective contribution in malaria prevention and treatment
Number of subjects: 293

Group type: EXPERIMENTAL
Intervention: Training for pharmacists
Number of subjects: 293
Study: 35940087

Group type: EXPERIMENTAL
Intervention: Low-dose ketamine infusion (0.5 mg/kg)
Number of subjects: 153

Group type: EXPERIMENTAL
Intervention: Intermittent theta-burst stimulation (iTBS)
Number of subjects: 153

Group type: EXPERIMENTAL
Intervention: 10-Hz rTMS
Number of subjects: 153

Group type: COMPARATOR
Intervention: Normal saline (control for ketamine)
Number of subjects: 153

Group type: COMPARATOR
Intervention: Sham stimulation (control for rTMS)
Number of subjects: 153
Study: 34521212

Group type: EXPERIMENTAL
Intervention: Cognitive Therapy (CT) or Interpersonal Psychotherapy (IPT)
Number of subjects: 182

Group type: COMPARATOR
Intervention: Waitlist Control
Number of subjects: 182
Study: 34027858

Group type: EXPERIMENTAL
Intervention: Intradermal platelet-rich plasma (PRP) 1 ml
Number of subjects: 64

Group type: COMPARATOR
Intervention: Intradermal tranexamic acid 4 mg
Number of subjects: 64
Study: 34990306

Group type: EXPERIMENTAL
Intervention: Narrative intervention (radio drama)
Number of subjects: 2904

Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 2904
Study: 33118206

Group type: EXPERIMENTAL
Intervention: Best possible selves intervention
Number of subjects: 74

Group type: COMPARATOR
Intervention: Control exercise
Number of subjects: 74
Study: 32358867

Group type: EXPERIMENTAL
Intervention: SUMI+ RBCs examined by immunocomplex capture fluorescence analysis (ICFA) using HIRO-305 and murine monoclonal antibodies against RBC membrane proteins carrying blood group antigens.
Number of subjects: 541522

Group type: EXPERIMENTAL
Intervention: Sanger sequencing and cloning of GYPA gene.
Number of subjects: 541522
Study: 35836170

Group type: EXPERIMENTAL
Intervention: Cabazitaxel
Number of subjects: 100

Group type: COMPARATOR
Intervention: Second ARTA
Number of subjects: 100
Study: 33057694

Group type: EXPERIMENTAL
Intervention: Internet-delivered CBT-I (Sleep Healthy Using the Internet [SHUTi])
Number of subjects: 303

Group type: COMPARATOR
Intervention: Patient education (PE)
Number of subjects: 303
Study: 35705380

Group type: EXPERIMENTAL
Intervention: 1,500 IU of hCG plus 450 IU of FSH
Number of subjects: 105

Group type: COMPARATOR
Intervention: Standard trigger dose of hCG (5,000 or 10,000 IU)
Number of subjects: 105
Study: 35221357

Group type: EXPERIMENTAL
Intervention: Prophylactic combination of glycopyrrolate, ondansetron, and ephedrine
Number of subjects: 100

Group type: COMPARATOR
Intervention: Standard treatment (ephedrine boluses as required)
Number of subjects: 100
Study: 34275887

Group type: EXPERIMENTAL
Intervention: Kinesio taping (KT)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Sham Kinesio taping (without tension)
Number of subjects: 30
Study: 33065708

Group type: EXPERIMENTAL
Intervention: Resisted sprint training group (RSTG, n = 20) using both weight vest and sled
Number of subjects: 34

Group type: COMPARATOR
Intervention: Control group (CONTG, n = 14)
Number of subjects: 34
Study: 32621696

Group type: EXPERIMENTAL
Intervention: Large container of petroleum jelly
Number of subjects: 128

Group type: COMPARATOR
Intervention: Small tube of petroleum jelly
Number of subjects: 128
Study: 34624179

Group type: EXPERIMENTAL
Intervention: Moderate-intensity exercise on treadmill
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Moderate-intensity exercise on cycle ergometer
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Perceived exertion during exercise
Number of subjects: 38
Study: 35288932

Group type: EXPERIMENTAL
Intervention: Fluoxetine
Number of subjects: 271

Group type: EXPERIMENTAL
Intervention: Duloxetine
Number of subjects: 271

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 271
Study: 32911375

Group type: EXPERIMENTAL
Intervention: Ibrutinib
Number of subjects: 105

Group type: COMPARATOR
Intervention: Ofatumumab or chlorambucil
Number of subjects: 105
Study: 33197560

Group type: EXPERIMENTAL
Intervention: Evolocumab
Number of subjects: 27564
Study: 32044091

Group type: COMPARATOR
Intervention: Labelling the number of doses per package
Number of subjects: 870

Group type: COMPARATOR
Intervention: Traffic Light System labelling
Number of subjects: 870
Study: 35984640

Group type: EXPERIMENTAL
Intervention: Structured education + intermittently scanned continuous glucose monitoring (isCGM)
Number of subjects: 126

Group type: COMPARATOR
Intervention: Standard care with blood glucose monitoring
Number of subjects: 126
Study: 34503491

Group type: EXPERIMENTAL
Intervention: Elemental sulfur (2% of concentrate dry matter)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Urea (4% of concentrate dry matter)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Fresh cassava root (300 mg of total substrate)
Number of subjects: 0
Study: 34406349

Group type: EXPERIMENTAL
Intervention: Adalimumab 40 mg
Number of subjects: 206

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 206
Study: 33251670

Group type: EXPERIMENTAL
Intervention: Empagliflozin
Number of subjects: 5988
Study: 34997849

Group type: EXPERIMENTAL
Intervention: LED photobiomodulation (PBM) with tooth bleaching
Number of subjects: 64

Group type: COMPARATOR
Intervention: Placebo group (simulation of irradiation with tooth bleaching)
Number of subjects: 64
Study: 33137453

Group type: EXPERIMENTAL
Intervention: Recruitment manoeuvre
Number of subjects: 230

Group type: COMPARATOR
Intervention: Control group with standard protective ventilation
Number of subjects: 230
Study: 32857839

Group type: EXPERIMENTAL
Intervention: Apalutamide
Number of subjects: 9215

Group type: EXPERIMENTAL
Intervention: Enzalutamide
Number of subjects: 9215

Group type: EXPERIMENTAL
Intervention: Darolutamide
Number of subjects: 9215

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9215
Study: 36226669

Group type: EXPERIMENTAL
Intervention: Tapinarof 1% cream
Number of subjects: 0

Group type: COMPARATOR
Intervention: Vehicle arm (control)
Number of subjects: 0
Study: 34808727

Group type: COMPARATOR
Intervention: Titanium palmar plating (TPP)
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: PEEK palmar plating (PPP)
Number of subjects: 31
Study: 32862716

Group type: EXPERIMENTAL
Intervention: Ticagrelor added to standard aspirin (80 mg or 100 mg)
Number of subjects: 499

Group type: COMPARATOR
Intervention: Placebo added to standard aspirin (80 mg or 100 mg)
Number of subjects: 499